Scientists hunt for early clues to stop cancer drug lung damage
NCT ID NCT07190703
Summary
This study aims to find early warning signs in the body that can detect lung inflammation caused by cancer drugs before it becomes severe. Researchers will analyze blood and lung fluid samples from 200 cancer patients to identify patterns that predict who is at risk. The goal is to help doctors catch this side effect early and manage it better to improve patient safety and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-TUMOR DRUG-ASSOCIATED INTERSTITIAL PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.